Cytomegalovirus

From Anthony Nolan Medical Guidelines
Jump to: navigation, search

Condition

Herpesvirus causing self-limiting infection in immunocompetent individuals, but with potentially severe consequences in immuno-suppressed transplant patients.

Individual at risk

Recipient

Guidance at RECRUITMENT

ACCEPTABLE

Guidance at CT

ACCEPTABLE

CMV IgG should be performed at CT to ascertain donor CMV serostatus.


Guidance at WORK-UP

CMV-IgG and IgM should be performed at work-up. If CMV IgM is postitive, CMV-PCR should be undertaken.

Testing outcomes and guidance

1

  CMV-IgM = negative, CMV-IgG = positive or negative 
  CMV-IgM = positive, CMV-IgG = positive, CMV-PCR negative 


Status information should be reported to the transplant centre

The donor can be cleared at workup.

If there is a change of CMV status from CT to work-up stage, the transplant centre should be informed immediately.

CMV-IgG weak positive results should be referred to reference lab for confirmation


2

  CMV-IgM = positive and CMV-IgG = negative and CMV-PCR=negative 

Donor can be cleared. Inform TC.



3

  CMV-PCR = positive 

Donor cannot be cleared. Deferred for 4-6 weeks and repeat CMV PCR then.

Inform transplant centre

Justification for guidance

CMV can cause devastating complications in post-transplant recipients. Accurate donor CMV serostatus plays an important role in donor selection.



References

Pergam SA, Xie H, Sandhu R, et al. Efficiency and Risk Factors for CMV Transmission in Seronegative Hematopoietic Stem Cell Recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012;18(9):1391-1400. doi:10.1016/j.bbmt.2012.02.008. [1]


Pseudonyms or Related Conditions

CMV

Version

Version 2, Edition 1

Date of Last Update

9 June 2016